InMode’s Energy-Based Devices Power Minimally Invasive Aesthetic Treatments
August 3, 2022
Trending News ☀️
InMode Ltd ($NASDAQ:INMD) manufactures and sells minimally invasive aesthetic medical devices for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.Non-invasive and minimally invasive aesthetic treatments like fat reduction, hair removal and muscle tightening rely on the use of medical devices powered by energy-based technologies like radio frequency and laser to achieve results without surgery. Demand for non-invasive treatments is on the rise because, compared to invasive procedures like traditional liposuction, patients don’t need to go under the surgeon’s scalpel. This increased demand for non-invasive aesthetic treatments powered by energy-based devices is likely to have a positive effect on InMode’s market share and earnings in the long term.
On Tuesday, INMODE stock opened at $33.9 and closed at $34.0. The company’s products are used by leading physicians and aesthetic practitioners around the world to provide patients with safe and effective results.
INMODE is a technology company that creates devices for aesthetic medicine. The company’s fundamentals reflect its long term potential, and the intrinsic value of INMODE shares is around $40.8, calculated by VI Line. Now INMODE stock is traded at $34.0, a fair price that is undervalued by 17%.
The company’s devices are based on proprietary technology that delivers energy through a unique electrode design. This design helps to minimize the risk of tissue damage and ensures that treatments are effective. InMode’s devices are FDA-approved and have been used by leading physicians worldwide. Despite this, InMode remains a strong investment opportunity due to the growing demand for minimally invasive aesthetic treatments. The company’s devices are backed by a proven track record of safety and efficacy, and its products are used by some of the world’s leading physicians.
Leave a Comment